[1]
“In Silico Study of the 5-Hydroxytryptamine-2C Receptor Antagonist Activity of Anthocyanins as Antidepressant Therapy”, JOMALISC, vol. 2, no. 1, pp. 88–95, May 2023, doi: 10.11113/jomalisc.v2.29.